Always up to date.
 

Our goal is to develop procedure and anatomy specific devices that lead in collaboration with our customers to predictable and superior treatment outcomes. Read on to learn more about our solutions, priorities, partnerships and how we create sustainable value with our teams.

Page 3 of 5.

Medartis Holding AG | Invitation Media and Investor conference | 2021 annual results

We are pleased to invite you to our FY 2021 results presentation on 7 March 2022. We will publish our media release, the Annual Report, and the conference presentation on our corporate website and...

Read more

Medartis accelerates sales growth to 29% in H1 2021 and improves profitability

  • Total net sales in the first six months rose by 29.2% at CER[1] vs. prior year (+20.6% vs. 2019)
  • All regions grew by more than 20% – CER growth was strongest in the US (46.3%), followed by APAC...
Read more

NEW
KeriMedical

Shaping the future together. Medartis is official distributor of KeriMedical products in selected markets. This strengthens Medartis’ extremities portfolio and is a significant step towards becoming a...

Read more

Page 3 of 5.